Physician profile
James Kim
NPI 1285808642
$2,245.73
in general payments reported to CMS, 2019-2025
14 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $1,058 · 2021: $85.74 · 2022: $158 · 2023: $122 · 2024: $519 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $854.78 | 2020 | |
| Alcon Vision LLC | $665.58 | 2019-2025 | Clareon, Argos, Tryptyr |
| Sight Sciences, INC. | $220.58 | 2024 | Omni Surgical System |
| Allergan, INC. | $193.03 | 2020-2021 | |
| Alimera Sciences, INC. | $66.06 | 2024 | Iluvien, Yutiq |
| Abbvie INC. | $53.65 | 2024-2025 | |
| Oyster Point Pharma, INC. | $35.26 | 2022-2023 | Tyrvaya |
| Pfizer INC. | $30.37 | 2023 | |
| Glaukos Corporation | $24.91 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.67 | 2019 | |
| Thea Pharma INC. | $23.01 | 2023 | Iyuzeh |
| Biotissue Holdings INC. | $18.80 | 2019 | |
| Aerie Pharmaceuticals, INC. | $18.30 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $17.73 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.